Skip to content

A head to head, prospective study on the diagnostic efficacy of 99mTc-CN7DG quantitative SPECT/CT imaging and 18F-FDG PET/CT imaging in metastatic tumors

A head to head, prospective study on the diagnostic efficacy of 99mTc-CN7DG quantitative SPECT/CT imaging and 18F-FDG PET/CT imaging in metastatic tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082187
Enrollment
Unknown
Registered
2024-03-22
Start date
2024-04-15
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic tumor

Interventions

Index test:99mTc-CN7DG SPECT/CT 18F-FDG PET/CT

Sponsors

the First Affiliated Hospital of the People's Liberation Army Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Age range from 18 to 80 years old; 2) Patients with metastatic or unresectable malignant tumors confirmed by pathological examination through puncture or open biopsy; 3) PS score = 1 point.

Exclusion criteria

Exclusion criteria: 1) Those without pathological result verification; 2) Severe cardiopulmonary dysfunction; 3) Those who are in deep coma or unable to lie flat for 1 hour to cooperate with the examination; 4) Minors, pregnant women, and lactating women; 5) Severe liver and kidney dysfunction (alanine aminotransferase exceeds the upper limit of normal by 8-10 times, serum creatinine is 186-442 umol/L); 6) Other situations that the researcher determines are not suitable as research subjects.

Design outcomes

Primary

MeasureTime frame
SUVmax;SUVmean;

Secondary

MeasureTime frame
tumor number;tumor size;SUVmax of liver;

Countries

China

Contacts

Public ContactGuoquan Li

the First Affiliated Hospital of the People's Liberation Army Air Force Military Medical University

2326604944@qq.com+86 29 8477 1048

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026